Applied DNA Sciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $565 | $199 | $304 | $983 |
Gross Profit | 266 | -167 | 5 | 370 |
EBITDA | -13,442 | -5,868 | -3,615 | -3,343 |
EBIT | -13,491 | -5,996 | -3,694 | -3,461 |
Net Income | -18,593 | -5,271 | -3,945 | -3,304 |
Net Change In Cash | 565 | 199 | 304 | 983 |
Free Cash Flow | -5,545 | -3,377 | -2,827 | -3,370 |
Cash | 2,450 | 1,667 | 4,727 | 6,823 |
Basic Shares | 8,942 | 1,662 | 572 | 118 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $2,136 | $3,431 | $13,367 | $18,168 |
Gross Profit | 838 | 1,016 | 5,533 | 5,053 |
EBITDA | -15,662 | -13,328 | -9,591 | -12,679 |
EBIT | -16,046 | -14,024 | -10,953 | -13,969 |
Net Income | -15,160 | -6,992 | -9,947 | -8,267 |
Net Change In Cash | 2,136 | 3,431 | 13,367 | 18,168 |
Free Cash Flow | -12,831 | -14,119 | -6,296 | -9,466 |
Cash | 1,667 | 6,431 | 7,151 | 15,215 |
Basic Shares | 517 | 105 | 17 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$2.08 |
2025-06-30 | $20.79 |
2025-03-31 | -$230.31 |
2024-12-31 | -$27.84 |
